Novel nerve-agent antidote design based on crystallographic and mass spectrometric analyses of tabun-conjugated acetylcholinesterase in complex with antidotes
about
Structure of HI-6*sarin-acetylcholinesterase determined by X-ray crystallography and molecular dynamics simulation: reactivator mechanism and designStructure-activity analysis of aging and reactivation of human butyrylcholinesterase inhibited by analogues of tabunSelective and Irreversible Inhibitors of Mosquito Acetylcholinesterases for Controlling Malaria and Other Mosquito-Borne DiseasesStructures of paraoxon-inhibited human acetylcholinesterase reveal perturbations of the acyl loop and the dimer interfaceButyrylcholinesterase for protection from organophosphorus poisons: catalytic complexities and hysteretic behaviorEnergetics of Ortho-7 (oxime drug) translocation through the active-site gorge of tabun conjugated acetylcholinesteraseIn silico studies in probing the role of kinetic and structural effects of different drugs for the reactivation of tabun-inhibited AChEFinding Inspiration in the Protein Data Bank to Chemically Antagonize Readers of the Histone Code.First principles calculations of thermodynamics and kinetic parameters and molecular dynamics simulations of acetylcholinesterase reactivators: can mouse data provide new insights into humans?Differential binding of bispyridinium oxime drugs with acetylcholinesterase.Why acetylcholinesterase reactivators do not work in butyrylcholinesterase.Novel selective and irreversible mosquito acetylcholinesterase inhibitors for controlling malaria and other mosquito-borne diseases.Reactivation of immobilized acetylcholinesterase-tabun complex by pralidoxime, its isomers, and homologs.Unbinding free energy of acetylcholinesterase bound oxime drugs along the gorge pathway from metadynamics-umbrella sampling investigation.Revealing the importance of linkers in K-series oxime reactivators for tabun-inhibited AChE using quantum chemical, docking and SMD studies.Can hydroxylamine be a more potent nucleophile for the reactivation of tabun-inhibited AChE than prototype oxime drugs? An answer derived from quantum chemical and steered molecular dynamics studies.The reactivation of tabun-inhibited mutant AChE with Ortho-7: steered molecular dynamics and quantum chemical studies.High-Throughput Screening for Positive Allosteric Modulators Identified Potential Therapeutics against Acetylcholinesterase Inhibition.In vitro and in vivo efficacy of PEGylated diisopropyl fluorophosphatase (DFPase)
P2860
Q21090062-9B061A89-C8F1-4AE4-8419-9FD81B15E3CDQ27654748-D69DA534-B0E3-4A24-8FB5-B95B2D94D550Q27657210-53409D5B-D651-408D-A4A8-C3175E003710Q27704889-E7055D03-C9A4-43FB-82C0-DA8568A6022BQ28393492-E8D53DE5-9184-4FD3-A3CE-0D8B7673D1CAQ28481270-53610276-CDF6-4D27-8925-BBF897337FD8Q28535578-F4BD55C2-B05B-4C1B-B0BA-E248CB00DD34Q31117873-CD5D7666-9301-4812-8872-BD462E95B748Q34316593-3701E99B-81DA-4D40-98C0-0C73E981EF69Q39013062-8BF658E9-CD20-47C0-B2C3-E45F2A4CED6EQ39934477-2896A8BE-AFB4-4D85-9401-F01D3A3CB82FQ42140490-2F4E1449-8E7F-44C4-BEE4-4C45D77035C1Q43108504-685505AB-B476-4BB1-9AEF-4785FB09EC67Q44157877-71DE2367-5B37-476D-B7B0-9E43B5D57B78Q48059059-7B0D994B-315E-4159-B467-D5B97AB964B1Q48695977-6C56B29A-5147-4DA4-87BB-716F4892D9DEQ50880167-B1ECE548-AF80-4835-BD4F-8F355109C05AQ53716874-9C55D2A7-9140-4F19-9052-F5155C266D8BQ57912695-4A75542A-5762-41A0-8FD8-3C086679028E
P2860
Novel nerve-agent antidote design based on crystallographic and mass spectrometric analyses of tabun-conjugated acetylcholinesterase in complex with antidotes
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
name
Novel nerve-agent antidote des ...... rase in complex with antidotes
@ast
Novel nerve-agent antidote des ...... rase in complex with antidotes
@en
Novel nerve-agent antidote des ...... rase in complex with antidotes
@nl
type
label
Novel nerve-agent antidote des ...... rase in complex with antidotes
@ast
Novel nerve-agent antidote des ...... rase in complex with antidotes
@en
Novel nerve-agent antidote des ...... rase in complex with antidotes
@nl
prefLabel
Novel nerve-agent antidote des ...... rase in complex with antidotes
@ast
Novel nerve-agent antidote des ...... rase in complex with antidotes
@en
Novel nerve-agent antidote des ...... rase in complex with antidotes
@nl
P2093
P356
P1476
Novel nerve-agent antidote des ...... rase in complex with antidotes
@en
P2093
P304
P356
10.1038/SJ.CLPT.6100151
P407
P577
2007-09-01T00:00:00Z